Programme
DAY 1 - 22 NOVEMBER 2010
08:00-08:30
Registration
08:30-09:00
Welcome & Opening Address
Paul Tam
Pro-Vice-Chancellor and Vice-President, University of Hong Kong, Hong Kong SAR
Alice Dautry
President, Institut Pasteur, Paris, France
09:00-09:50
Session 1: Keynote Lecture
L01 - HIV/AIDS, more than 25 years later: which challenges remain?
Françoise Barré-Sinoussi (Institut Pasteur, France)
Presentation (pdf file)
09:50-10:10
Session 2: Vaccine Preventable Diseases
O01 - Tuberculosis but not Immune Reconstitution Inflammatory Syndrome (IRIS) prevents early and late NK cell degranulation reconstitution in HIV/TB co-infected patients
Polidy Pean et al. (Institut Pasteur Cambodia, Cambodia)
10:10-10:40
L02 - The development of an AIDS mucosal vaccine
Zhiwei Chen (University of Hong Kong, Hong Kong)
10:40-11:10
Break
11:10-11h40
L03 - Universal vaccine for influenza A virus
Leo LM Poon (University of Hong Kong, Hong Kong SAR)
Presentation (pdf file)
11:40-12:00
O02 - NS1-mediated delay of immune activation contributes to influenza A virulence in ferrets
Isabelle Meunier, Veronika von Messling (INRS-Institut Armand-Frappier, University of Quebec, Laval, Canada)
12:00-12:20
O03 - Genetic determinants of hepatitis B vaccine response
Eileen Png et al. (Genome Institute of Singapore, Singapore)
12:20-12:50
L04 - Vaccines for Neglected Diseases: Challenges and Opportunities
Allan Saul (Novartis Vaccines Institute for Global Health, Italy)
12:40-14:30
Lunch and Poster Session
14:30-15:00
Session 3: Neglected Diseases
L05 - Buruli ulcer disease: Challenges and Opportunities for Institut Pasteur International Network
Sara Eyangoh (Centre Pasteur du Cameroun, Yaoundé, Cameroon)
Presentation (pdf file)
15:00-15:20
O04 - Asian Network for Molecular diagnosis of primary immunodeficiencies
Yu Lung Lau (LKS Faculty of Medicine, The University of Hong Kong, Hong Kong)
15:20-15:40
O05 – Characterization of immunomodulatory activity of eIF4A protein
Mourad Barhoumi (Institut Pasteur de Tunis, Tunisia)
15:40-16:00
O06 – Novel strategy using live non‐pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
Sima Rafati (Pasteur Institute of Ian, Tehran, Iran)
16:00-16:30
Break
16:30-16:50
O07 - Trypanosoma cruzi produces a population of tRNA-derived small RNAs which are recruited to specific cytoplasmic granules and secreted to the extracellular medium
MR Garcia Silva (Institut Pasteur de Montevideo, Uruguay)
16:50-17:10
O08 - Chikungunya, a new threat propagated by the cosmopolite Aedes albopictus
Marie Vazeille et al. (Institut Pasteur, Paris, France)
17:10-17:40
L06 - Phenomic technologies in drug discovery of Neglected Diseases
Ulf Nehrbass (Institut Pasteur-Korea, Korea)
17:40-20:30